AKCEA-APOCIII-LRx in healthy volunteers with hypertriglyceridaemia (NCT02900027)

AKCEA-APOCIII-LRx improved atherogenic lipid profile with a favourable safety and tolerability profile.

Please login or create a FREE account to view this content

Educational partners and supporters

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Ionis Logo

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Kowa Logo